Entries by Ursula Tschorn

Brexit Drug Supply

Brexit Drug Supply Brexit – is the after Brexit drug supply in Europe at risk? The German Federal Association of Pharmaceutical Manufacturers (BAH) sees the Brexit drug supply in Europe at risk, when Britain leaves the EU on the 29.3.2019. Neither the UK itself nor the EU, in the opinion of the BAH, are well […]

SMS, G-SRS, GINAS, EU-SRS Current Status July 2018

SMS, G-SRS, GINAS, EU-SRS Current Status of the IDMP Substance Submodel Implementations in Europe and the US By Dieter Schlaps for IDMP1-News July 2018 The SMS, G-SRS, GINAS, EU-SRS Current Status as of July 2018 is beeing summarised in this blog article. FDA’s G-SRS System In FDA2‘s G-SRS1 system, the substance is registered per type, […]

Decision on EMA Relocation has been published

Decision on EMA relocation has been published The EMA is currently based in London’s Docklands business district but must move when Britain leaves the bloc in March 2019. EU agencies are not allowed to be based outside the union. The fight for one of the most prised spoils of Brexit has come to a climax […]